Clinical Trial Update: Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial UPDATE evaluating day regimens of Conbercept on cytokine levels in Proliferative diabetic retinopathy patients undergoing vitrectomy (CON…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Proliferative Diabetic Retinopathy, VEGF Overexpression | Phase 4 | Status: UNKNOWN